Our findings indicated that Lin28A may have a pivotal role in AML tumorigenesis and chemoresistance by modulating CENPE, and that targeting Lin28A/CENPE could be a potential effective treatment or combined chemotherapy regimen for chemoresistant AML patients. This evidence concerns the gene LIN28A and acute myeloid leukemia.